Instrument Inactif

Autres langues MANA CAPI

Actions

MAAQ

US56168P1049

Autres langues

07/11/22	Mana Capital Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
31/10/22	MANA CAPI : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K
26/10/22	Mana Capital, Cardio Diagnostics Complete Merger
25/10/22	Mana Capital Acquisition Corp.(NasdaqGM:MAAQ) dropped from NASDAQ Composite Index
25/10/22	Cardio Diagnostics Inc. completed the acquisition of Mana Capital Acquisition Corp. from a group of shareholders in a reverse merger transaction.
10/10/22	Mana Capital Acquisition Corp. Announces Effectiveness of Registration Statement and October 25, 2022 Special Meeting of Stockholders to Approve Business Combination with Cardio Diagnostics, Inc.
23/09/22	MANA CAPITAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits (form 8-K)
23/09/22	Mana Capital Acquisition Corp. Confirms Second Contribution to Trust Account to Extend Time Period to Complete a Business Combination
22/09/22	Mana Capital Acquisition Corp. Announces Intention to Further Extend Period to Consummate Initial Business Combination
21/09/22	Mana Capital Acquisition : Cardio Diagnostics Announces Issuance of U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease - Form 8-K
21/09/22	MANA CAPITAL ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
15/09/22	MANA CAPITAL ACQUISITION CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
26/08/22	MANA CAPITAL ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
25/08/22	MANA CAPITAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits (form 8-K)
25/08/22	Mana Capital Acquisition Corp. Confirms Contribution to Trust Account to Extend Time Period to Complete a Business Combination
23/08/22	Mana Capital Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination
10/08/22	MANA CAPITAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
10/08/22	Mana Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
31/05/22	Mana Capital Acquisition : and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics - Form 8-K
31/05/22	MANA CAPITAL ACQUISITION CORP. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
31/05/22	Cardio Diagnostics to Go Public Through Merger With Mana Capital Acquisition
31/05/22	Mana Capital Acquisition Corp. and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics
31/05/22	Cardio Diagnostics Inc. entered into a definitive business combination agreement to acquire Mana Capital Acquisition Corp. from a group of shareholders for approximately $110 million in a reverse merger transaction.
12/05/22	MANA CAPITAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
12/05/22	Mana Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022